CVE-2010-1333

Description

Multiple cross-site scripting (XSS) vulnerabilities in Almas Inc. Compiere J300_A02 and earlier allow remote attackers to inject arbitrary web script or HTML via unspecified vectors.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.70% Top 30%
Vendor Advisory secunia.com Vendor Advisory compiere-japan.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.compiere-japan.com/products/release/patch.html patch vendor advisory
http://jvndb.jvn.jp/ja/contents/2010/JVNDB-2010-000009.html third party advisory
http://jvn.jp/en/jp/JVN38687002/index.html third party advisory
http://jvndb.jvn.jp/ja/contents/2010/JVNDB-2010-000008.html third party advisory
http://osvdb.org/63419 vdb entry
https://exchange.xforce.ibmcloud.com/vulnerabilities/57494 vdb entry
http://jvn.jp/en/jp/JVN57963254/index.html third party advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/57493 vdb entry
http://secunia.com/advisories/39177 third party advisory vendor advisory

Frequently Asked Questions

What is the severity of CVE-2010-1333?
CVE-2010-1333 has been scored as a medium severity vulnerability.
How to fix CVE-2010-1333?
To fix CVE-2010-1333, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2010-1333 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2010-1333 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.